is a topic covered in the Davis's Drug Guide
To view the entire topic, please sign in or purchase a subscription.
The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:
-- The first section of this topic is shown below --
temporary class platelet-derived growth factor receptor alpha blockers
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Quiring, Courtney, et al. "Olaratumab." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110588/all/olaratumab.
Quiring C, Sanoski CA, Vallerand AH. Olaratumab. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110588/all/olaratumab. Accessed October 22, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Olaratumab. In Davis's Drug Guide. Available from https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110588/all/olaratumab
Quiring C, Sanoski CA, Vallerand AH. Olaratumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 October 22]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110588/all/olaratumab.
TY - ELEC
T1 - olaratumab
ID - 110588
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110588/all/olaratumab
PB - F.A. Davis Company
ET - 16
DB - Washington Manual
DP - Unbound Medicine